세계의 저분자 원료의약품(API) 시장 리포트(2023년)

“Small Molecule Active Pharmaceutical Ingredient Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule active pharmaceutical ingredient market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule active pharmaceutical ingredient? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The small molecule active pharmaceutical ingredient market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Synthetic; Chemical; Biological

• 2) By Therapeutic Type: Autoimmune Diseases; Oncology; Metabolic Diseases; Ophthalmology; Cardiovascular Diseases; Infectious Diseases; Neurology; Respiratory Disorders; Dermatology; Urology

• 3) By Manufacturing Method: In-House; Contract

• 4) By Application: Clinical; Commercial

• Companies Mentioned: Albemarle Corporation; Aurobindo Pharma Limited; Dr Reddy's Laboratories Limited; GSK plc; Merck KGaA

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the market are: Albemarle Corporation, Aurobindo Pharma Limited, Dr Reddy's Laboratories Limited, GSK plc, Merck KGaA, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Johnson Matthey, Gilead Sciences Inc., Allergan Plc, Cambrex Corporation, Siegfried Holding AG, BASF SE, Sanofi SA, Albany Molecular Research Inc., AstraZeneca Plc, and Hoffmann-La Roche Limited.

The global small molecule active pharmaceutical ingredient market is expected to grow from $167.59 billion in 2022 to $180.76 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The small molecule active pharmaceutical ingredient market is expected to grow to $241.11 billion in 2027 at a CAGR of 7.5%.

The small molecule active pharmaceutical ingredient market consists of sales of standard API, HPAPI (high potency active pharmaceutical ingredients), branded synthetic API, generic synthetic API, and semi-synthetic API. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

A small molecule active pharmaceutical ingredient (API) is any substance or mixture of organic substances or compounds with low molecular weight intended to be used as the active ingredient in the manufacture of a drug or medicinal product. A small molecule active pharmaceutical ingredient (API) is used as raw materials in the manufacturing of pharmaceutical drugs.

North America was the largest region in the small molecule active pharmaceutical ingredient market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule active pharmaceutical ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of small molecule active pharmaceutical ingredient markets are synthetic, chemical, and biological. Synthetics are engaged in the manufacturing of pharmaceutical drugs. Synthetic chemical APIs, also known as small molecules, constitute a large part of the pharmaceutical market, with many small molecule drugs commercially available in the market. The various therapeutic types are autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders, dermatology, and urology. The manufacturing methods are in-house and contract. The applications are clinical and commercial.

The increasing prevalence of diseases is a major driver propelling the small molecule active pharmaceutical ingredient (API) market. A disease is a particular abnormal condition, a disorder of a structure or function, that affects the body of the patient. Active pharmaceutical ingredients (APIs) are the active components in a pharmaceutical drug that produce the required effect on the body to treat various conditions. For instance, according to the data by World health Organization (WHO), a body of the United Nations responsible for international public health, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. And, in 2020, the bulk of the approximately 422 million individuals with diabetes globally reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually. Cardiovascular diseases have resulted in the deaths of 17.9 million people worldwide. Therefore, the increasing prevalence of diseases will continue to be the key driver in the small molecule API market.

Strategic partnerships and collaborations have emerged as the key trend gaining popularity in the small molecule active pharmaceutical ingredient market. Key players operating in the small molecule active pharmaceutical ingredient sector are focused on partnerships and collaborations to reinforce their position. For instance, in May 2022, NovAliX, a France-based drug discovery company, Alysophil a France-based company creating new industrial chemistry based on continuous flow chemistry, De Dietrich Process Systems, a France-based provider of solutions for the fine chemical and pharmaceutical industries, and Bruker, a US-based manufacturer of scientific instruments for molecular and materials research collaborated. Through this partnership, the companies aim to jointly develop a new approach to active pharmaceutical ingredient (API) production and offer complete, standalone, and location-independent API manufacturing solutions to pharmaceutical companies or contract manufacturing organizations (CMO).

In March 2021, Piramal Pharma, an India-based pharmaceutical company acquired Hemmo Pharmaceuticals for a deal amount of $7.75 billion (775 crores). Through this acquisition, Piramal pharma aims to gain access to the growing peptide active pharmaceutical ingredients (API) market. Hemmo pharmaceutical is an India-based manufacturer that produces peptide products and custom peptide synthesis.

The countries covered in the small molecule active pharmaceutical ingredient market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The small molecule active pharmaceutical ingredient market research report is one of a series of new reports from The Business Research Company that provides small molecule active pharmaceutical ingredient market statistics, including small molecule active pharmaceutical ingredient industry global market size, regional shares, competitors with an small molecule active pharmaceutical ingredient market share, detailed small molecule active pharmaceutical ingredient market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule active pharmaceutical ingredient industry. This small molecule active pharmaceutical ingredient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Small Molecule Active Pharmaceutical Ingredient Market Characteristics

3. Small Molecule Active Pharmaceutical Ingredient Market Trends And Strategies

4. Small Molecule Active Pharmaceutical Ingredient Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Small Molecule Active Pharmaceutical Ingredient Market
• 4.2. Ukraine-Russia War Impact On Small Molecule Active Pharmaceutical Ingredient Market
• 4.3. Impact Of High Inflation On Small Molecule Active Pharmaceutical Ingredient Market

5. Small Molecule Active Pharmaceutical Ingredient Market Size And Growth

• 5.1. Global Small Molecule Active Pharmaceutical Ingredient Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Small Molecule Active Pharmaceutical Ingredient Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Small Molecule Active Pharmaceutical Ingredient Market Segmentation

• 6.1. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Synthetic
• Chemical
• Biological
• 6.2. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Therapeutic Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Autoimmune Diseases
• Oncology
• Metabolic Diseases
• Ophthalmology
• Cardiovascular Diseases
• Infectious Diseases
• Neurology
• Respiratory Disorders
• Dermatology
• Urology
• 6.3. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Manufacturing Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• In-House
• Contract
• 6.4. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Clinical
• Commercial

7. Small Molecule Active Pharmaceutical Ingredient Market Regional And Country Analysis

• 7.1. Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market

• 8.1. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Small Molecule Active Pharmaceutical Ingredient Market

• 9.1. China Small Molecule Active Pharmaceutical Ingredient Market Overview
• 9.2. China Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Small Molecule Active Pharmaceutical Ingredient Market

• 10.1. India Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Small Molecule Active Pharmaceutical Ingredient Market

• 11.1. Japan Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Small Molecule Active Pharmaceutical Ingredient Market

• 12.1. Australia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Small Molecule Active Pharmaceutical Ingredient Market

• 13.1. Indonesia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Small Molecule Active Pharmaceutical Ingredient Market

• 14.1. South Korea Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Small Molecule Active Pharmaceutical Ingredient Market

• 15.1. Western Europe Small Molecule Active Pharmaceutical Ingredient Market Overview
• 15.2. Western Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Small Molecule Active Pharmaceutical Ingredient Market

• 16.1. UK Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Small Molecule Active Pharmaceutical Ingredient Market

• 17.1. Germany Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Small Molecule Active Pharmaceutical Ingredient Market

• 18.4. France Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.5. France Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market

• 19.1. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market Overview
• 19.2. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Small Molecule Active Pharmaceutical Ingredient Market

• 20.1. Russia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Small Molecule Active Pharmaceutical Ingredient Market

• 21.1. North America Small Molecule Active Pharmaceutical Ingredient Market Overview
• 21.2. North America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Small Molecule Active Pharmaceutical Ingredient Market

• 22.1. USA Small Molecule Active Pharmaceutical Ingredient Market Overview
• 22.2. USA Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Small Molecule Active Pharmaceutical Ingredient Market

• 23.1. South America Small Molecule Active Pharmaceutical Ingredient Market Overview
• 23.2. South America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Small Molecule Active Pharmaceutical Ingredient Market

• 24.1. Brazil Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Small Molecule Active Pharmaceutical Ingredient Market

• 25.1. Middle East Small Molecule Active Pharmaceutical Ingredient Market Overview
• 25.2. Middle East Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Small Molecule Active Pharmaceutical Ingredient Market

• 26.1. Africa Small Molecule Active Pharmaceutical Ingredient Market Overview
• 26.2. Africa Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Small Molecule Active Pharmaceutical Ingredient Market Competitive Landscape And Company Profiles

• 27.1. Small Molecule Active Pharmaceutical Ingredient Market Competitive Landscape
• 27.2. Small Molecule Active Pharmaceutical Ingredient Market Company Profiles
  • 27.2.1. Albemarle Corporation
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Aurobindo Pharma Limited
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Dr Reddy's Laboratories Limited
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. GSK plc
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Merck KGaA
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Small Molecule Active Pharmaceutical Ingredient Market

29. Small Molecule Active Pharmaceutical Ingredient Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer